Skip to main content
. Author manuscript; available in PMC: 2014 Mar 9.
Published in final edited form as: Am J Gastroenterol. 2013 Jan 8;108(3):410–415. doi: 10.1038/ajg.2012.442

Table 4.

Unadjusted and adjusted risk of post-ERCP pancreatitis, by group

Study group Unadjusted risk (%) Risk after risk score adjustment (%) Risk after propensity score adjustment (%)
No prophylaxis (n=58) 20.7 25.7 23.1
PD stent alone (n=249) 16.1 15.3 15.7
Indomethacin and PD stent (n=247) 9.7 9.4 9.5
Indomethacin alone (n=48) 6.3 7.8 7.1

ERCP, endoscopic retrograde cholangiopancreatography; PD, pancreatic duct.